177 related articles for article (PubMed ID: 17134965)
1. Gene expression regulation and cancer.
Delgado MD; León J
Clin Transl Oncol; 2006 Nov; 8(11):780-7. PubMed ID: 17134965
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of gene expression and recent advance on transcription studies].
Tamura T; Makino Y; Kishimoto T
Nihon Rinsho; 1995 Apr; 53(4):1033-47. PubMed ID: 7752463
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-mediated induction of rat prolactin gene transcription requires the formation of a chromatin loop between the distal enhancer and proximal promoter regions.
Gothard LQ; Hibbard JC; Seyfred MA
Mol Endocrinol; 1996 Feb; 10(2):185-95. PubMed ID: 8825558
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques.
Petrovic J; Zhou Y; Fasolino M; Goldman N; Schwartz GW; Mumbach MR; Nguyen SC; Rome KS; Sela Y; Zapataro Z; Blacklow SC; Kruhlak MJ; Shi J; Aster JC; Joyce EF; Little SC; Vahedi G; Pear WS; Faryabi RB
Mol Cell; 2019 Mar; 73(6):1174-1190.e12. PubMed ID: 30745086
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of enhancer-promoter communication during differentiation-induced gene activation.
Hatzis P; Talianidis I
Mol Cell; 2002 Dec; 10(6):1467-77. PubMed ID: 12504020
[TBL] [Abstract][Full Text] [Related]
6. The role of enhancers as centres for general transcription factor recruitment.
Szutorisz H; Dillon N; Tora L
Trends Biochem Sci; 2005 Nov; 30(11):593-9. PubMed ID: 16126390
[TBL] [Abstract][Full Text] [Related]
7. Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers.
Kabotyanski EB; Huetter M; Xian W; Rijnkels M; Rosen JM
Mol Endocrinol; 2006 Oct; 20(10):2355-68. PubMed ID: 16772529
[TBL] [Abstract][Full Text] [Related]
8. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
9. Genetic lesions and perturbation of chromatin architecture: a road to cell transformation.
Chakraborty S; Senyuk V; Nucifora G
J Cell Biochem; 2001; 82(2):310-25. PubMed ID: 11527156
[TBL] [Abstract][Full Text] [Related]
10. A unique enhancer boundary complex on the mouse ribosomal RNA genes persists after loss of Rrn3 or UBF and the inactivation of RNA polymerase I transcription.
Herdman C; Mars JC; Stefanovsky VY; Tremblay MG; Sabourin-Felix M; Lindsay H; Robinson MD; Moss T
PLoS Genet; 2017 Jul; 13(7):e1006899. PubMed ID: 28715449
[TBL] [Abstract][Full Text] [Related]
11. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
12. A major role for the TATA box in recruitment of chromatin modifying complexes to a globin gene promoter.
Gui CY; Dean A
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7009-14. PubMed ID: 12773626
[TBL] [Abstract][Full Text] [Related]
13. Enhancer function regulated by combinations of transcription factors and cofactors.
Nakagawa T; Yoneda M; Higashi M; Ohkuma Y; Ito T
Genes Cells; 2018 Oct; 23(10):808-821. PubMed ID: 30092612
[TBL] [Abstract][Full Text] [Related]
14. Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation.
Krumm A; Hickey LB; Groudine M
Genes Dev; 1995 Mar; 9(5):559-72. PubMed ID: 7698646
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
16. The beta -globin locus control region (LCR) functions primarily by enhancing the transition from transcription initiation to elongation.
Sawado T; Halow J; Bender MA; Groudine M
Genes Dev; 2003 Apr; 17(8):1009-18. PubMed ID: 12672691
[TBL] [Abstract][Full Text] [Related]
17. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions.
Ward SB; Hernandez-Hoyos G; Chen F; Waterman M; Reeves R; Rothenberg EV
Nucleic Acids Res; 1998 Jun; 26(12):2923-34. PubMed ID: 9611237
[TBL] [Abstract][Full Text] [Related]
18. The histone acetyltransferase activity of PCAF cooperates with the brahma/SWI2-related protein BRG-1 in the activation of the enhancer A of the MHC class I promoter.
Brockmann D; Lehmkühler O; Schmücker U; Esche H
Gene; 2001 Oct; 277(1-2):111-20. PubMed ID: 11602348
[TBL] [Abstract][Full Text] [Related]
19. A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected].
Khan I; Zakaria MK; Kumar M; Mani P; Chattopadhyay P; Sarkar DP; Sinha S
J Transl Med; 2015 Aug; 13():254. PubMed ID: 26242403
[TBL] [Abstract][Full Text] [Related]
20. Chromatin architecture underpinning transcription elongation.
Lee K; Blobel GA
Nucleus; 2016 Jul; 7(4):1-8. PubMed ID: 27366856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
